News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO)'s Decision To Pull Mixtard 30 Insulin Drug Could Add £9 Million To NHS Drugs Bill In England Alone


8/4/2010 8:29:06 AM

Medical News Today -- Pharmaceutical company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics Bulletin (DTB) (a BMJ publication).


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES